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I N T R O D U C T I O N
Purinergic P2X receptors (P2XRs) are ATP-gated cation 
channels. Seven mammalian receptor subunits, denoted 
P2X1  through  P2X7,  and  several  spliced  forms  of 
these subunits have been identified. Each subunit has 
only two transmembrane (TM) domains, the N and C ter-
mini facing the cytoplasm, and a large extracellular 
loop.  These  subunits  assemble  together  as  homo-  or 
heterotrimers  to  make  functional  receptors  (North, 
2002). P2XRs likely have three intersubunit orthosteric 
binding sites located in the ectodomain, and their full 
occupancy appears to be required for conformational 
changes in the TM channel gate, leading to facilitation 
of cation influx through the channel pore (Marquez-
Klaka et al., 2007; Browne et al., 2010). All P2XRs are 
permeable to Na
+, K
+, and Ca
2+, and some are also per-
meable to Cl
 (Egan et al., 2006). Positive and negative 
allosteric modulators of P2XRs interact with binding 
sites that are topologically distinct from the orthosteric 
sites  recognized  by  the  receptor  endogenous  agonist 
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ATP, causing conformational changes that profoundly 
influence the gating of P2XRs (Coddou et al., 2011). In 
general, it is difficult to explore experimentally the inter-
actions between binding of orthosteric and allosteric 
ligands and gating because simultaneous assessment 
of ligand binding and channel gating is not possible. 
Therefore, understanding ligand-gated systems pre-
dominantly depends on development of a kinetic model 
(Colquhoun, 1998).
The P2X7R is an unusual member of this family of 
channels.  Structurally,  the  P2X7  subunit  is  distin-
guished from other subunits by its long intracellular   
C-terminal tail containing multiple protein and lipid   
interaction  motifs  and  a  cysteine-rich  18–amino  acid 
segment (Surprenant et al., 1996) and by its inability to 
make stable heteromeric complexes (Torres et al., 1999; 
Nicke, 2008). It also appears that this channel exhibits 
different permeability states (Yan et al., 2008), which 
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Among purinergic P2X receptor (P2XR) channels, the P2X7R exhibits the most complex gating kinetics; the bind-
ing of orthosteric agonists at the ectodomain induces a conformational change in the receptor complex that favors 
a gating transition from closed to open and dilated states. Bath Ca
2+ affects P2X7R gating through a still uncharac-
terized mechanism: it could act by reducing the adenosine triphosphate
4 (ATP
4) concentration (a form pro-
posed to be the P2X7R orthosteric agonist), as an allosteric modulator, and/or by directly altering the selectivity 
of pore to cations. In this study, we combined biophysical and mathematical approaches to clarify the role of cal-
cium in P2X7R gating. In naive receptors, bath calcium affected the activation permeability dynamics indirectly by 
decreasing the potency of orthosteric agonists in a concentration-dependent manner and independently of the 
concentrations of the free acid form of agonists and status of pannexin-1 (Panx1) channels. Bath calcium also fa-
cilitated the rates of receptor deactivation in a concentration-dependent manner but did not affect a progressive 
delay in receptor deactivation caused by repetitive agonist application. The effects of calcium on the kinetics of re-
ceptor deactivation were rapid and reversible. A438079, a potent orthosteric competitive antagonist, protected the 
rebinding effect of 2’(3)-O-4-benzoylbenzoyl)ATP on the kinetics of current decay during the washout period, but 
in the presence of A438079, calcium also increased the rate of receptor deactivation. The corresponding kinetic 
(Markov state) model indicated that the decrease in binding affinity leads to a decrease in current amplitudes and 
facilitation of receptor deactivation, both in an extracellular calcium concentration–dependent manner expressed 
as a Hill function. The results indicate that calcium in physiological concentrations acts as a negative allosteric 
modulator of P2X7R by decreasing the affinity of receptors for orthosteric ligand agonists, but not antagonists, and 
not by affecting the permeability dynamics directly or indirectly through Panx1 channels. We expect these results 
to generalize to other P2XRs.
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and 5 µl Lipofectamine 2000 reagent (Invitrogen) in 2 ml of   
serum-free Opti-MEM (Invitrogen). After 4.5 h of incubation, the 
transfection mixture was replaced with normal culture medium, 
and cells were cultured for an additional 24–48 h. Transfected 
cells  were  mechanically  dispersed  and  recultured  on  35-mm 
dishes for 2–10 h.
Current measurements
Whole-cell  patch-clamp  recordings  were  performed  with  single 
cells  at  room  temperature  using  an  Axopatch  200B  amplifier 
(Axon  Instruments)  as  described  previously  (Yan  et  al.,  2005). 
Patch electrodes, fabricated from borosilicate glass (type 1B150F-
3; World Precision Instruments, Inc.) using a Flaming Brown hori-
zontal puller (P-97; Sutter Instrument), were heat polished to a 
final tip resistance of 3.5–5.5 Mohm. All current recordings were 
programmed, captured, and stored using the pClamp 8.0 software 
packages in conjunction with a converter (Digidata 1322A A/D; 
Axon Instruments). Experiments were performed on single cells 
with a mean capacitance of 10 pF. Unless otherwise stated, mem-
brane potential was held at 60 mV. Current–voltage relations 
were used to estimate changes in reversal potential during agonist 
application and were obtained by voltage ramps from 80 to 80 mV 
delivered twice per second during 50 s. Patch electrodes were 
filled with solution containing 145 mM NaCl, 10 mM EGTA, and 
10 mM HEPES; the pH was adjusted with 10 M NaOH to 7.35. The 
osmolarity of this solution was 305 mosM. Krebs-Ringer–like bath 
buffer contained 147 mM NaCl, 3 mM KCl, 1 mM MgCl2, 0–10 mM 
CaCl2, 10 mM glucose, and 10 mM HEPES; the pH was adjusted   
to 7.35 with 10 M NaOH. In some experiments, ATP and BzATP 
solutions were prepared daily in bath buffer with pH properly re-
adjusted  and  were  applied  using  either  an  Ultrafast  Solution-
Switching System (LSS-3200; EXFO Burleigh Products Group Inc.) 
that was simultaneously program controlled by pClamp 8.0 soft-
ware through a PZ-150M amplifier (Yan et al., 2006) or an RSC-200 
Rapid Solution Changer (Biological). Cells with enhanced green 
fluorescent protein fluorescence were identified before immers-
ing the electrode in bath solution for a gigaohm seal.
Measurements of free calcium concentrations in bath medium
Measurements of free calcium ion concentration in bath medium 
with or without ATP and BzATP were made with a plastic mem-
brane combination calcium ion selective electrode (ionplus Sure-
Flow; Thermo Fisher Scientific). ATP (Sigma-Aldrich) and BzATP 
(Sigma-Aldrich) were weighed to prepare the 10-mM stock solu-
tion in deionized water according to the free acid formula weight 
on the product label. The Mg
2+-free sodium background buffer 
consisted of 147 mM NaCl, 3 mM KCl, 10 mM glucose, and 10 mM 
HEPES, and the pH was properly adjusted to 7.35 with NaOH. The 
0.95-mM Ca
2+ buffer was prepared by addition of 0.1 M Ca
2+ stan-
dard (Thermo Fisher Scientific) to the background buffer. 320-, 
100-, 32-, 10-, 3.2-, 1-, and 0-µM ATP or BzATP solutions were pre-
pared by addition of the same 480-µl sum volume of various com-
binations of pure water and 10-mM ATP or BzATP stock solution 
into the 19.6 ml of 0.95-mM Ca
2+ buffer. To generate a standard 
curve, a real-time recording of the millivolt reading of the calcium 
ion selective electrode was performed with an Orion 4-Star reader 
(Thermo Fisher Scientific), and the standard curve was calcu-
lated by semilogarithmic fitting using KaleidaGraph v 4.1 (Synergy   
Software). After the standard curve recording, the millivolt read-
ings of different ATP or BzATP solutions were collected, and the 
test-free Ca
2+ concentrations were derived from the standard curve.
Calculations
Whenever appropriate, the data were presented as mean ± SEM 
values. Significant differences, with P < 0.01, were determined by 
Mann-Whitney test using InStat 3.05 (GraphPad Software). Non-
linear curve fitting of deactivation currents was performed with the 
further complicates the understanding of coupling of 
conformational  changes  in  the  orthosteric  binding 
domains with the corresponding changes at the TM 
channel gate. The binding of Ca
2+ and Mg
2+ to - and   
-phosphate groups of ATP is a well-established phe-
nomenon (Jahngen and Rossomando, 1983), but at the 
present time it is unknown which form of ATP (ATP
4 
and/or Mg/Ca-ATP) acts as an orthosteric agonist for 
this receptor (Jiang, 2009). It has also not been clarified 
whether these two macroelements affect the receptor 
function by acting as allosteric modulators, as earlier 
data suggest (Virginio et al., 1997), and/or by altering 
the permeability dynamics, as shown for P2X4R (Khakh 
et al., 1999). Furthermore, it is unknown how allosteric 
modulators affect P2X7R gating by changing the af-
finity of receptors for ATP and/or the strength of gat-
ing, i.e., the transduction of signals from orthosteric 
binding domains to the receptor gate. Finally, the inter-
action  between  allosteric  agonists/antagonists  and 
orthosteric antagonists has not been examined previ-
ously for P2X7R.
In this study, we combined biophysical and mathe-
matical approaches to address these questions. To ex-
amine the influence of bath Ca
2+ on the permeability 
dynamics,  we  performed  full  concentration  response 
studies using ATP and 2’(3)-O-4-benzoylbenzoyl)ATP 
(BzATP)  as  orthosteric  agonists  in  naive  cells  (not 
previously exposed to orthosteric agonists) bathed in 
Ca
2+-containing and Ca
2+-deficient medium. To clarify 
whether Ca
2+ affects P2X7R by reducing the free acid 
concentration of agonist, we manipulated total agonist 
and Ca
2+ concentration, resulting in either fixed or pro-
gressively  increased  free  acid  agonist  concentration.   
We also studied the influence of Ca
2+ on receptor be-
havior by analyzing the rates of decay of current after 
washout  of  agonists  or  application  of  a  competitive   
orthosteric antagonist, termed current or receptor de-
activation.  Based  on  experimental  data,  we  revised  a 
previously published Markov state model (Yan et al., 
2010)  to  describe  regulation  of  P2X7R  by  bath  cal-
cium, which provides a better understanding of the 
dynamics  of  these  receptors  under  orthosteric  and   
allosteric regulation.
M A T E R I A L S   A N D   M E T H O D S
Cell culture and transfection
Human embryonic kidney 293 (HEK293) cells were used for the 
expression of wild-type and mutant P2X7Rs, as described previ-
ously (He et al., 2003; Yan et al., 2006). These cells were obtained 
from the American Type Culture Collection and were routinely 
maintained in Dulbecco’s modified Eagle’s medium containing 
10% (vol/vol) fetal bovine serum (Invitrogen) and 1% (vol/vol) 
penicillin–streptomycin liquid (Invitrogen) in a tissue culture in-
cubator. For electrophysiological measurements, cells were grown 
on 35-mm dishes at a density of 0.5 × 10
6 cells per dish. Transfec-
tion was conducted 24 h after plating the cells using 2 µg DNA   Yan et al. 439
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where A is the applied agonist concentration and Li, i = 1–3, are 
the rates of sensitization/loss of sensitization. The whole-cell cur-
rent is then given by
  I g Q Q V E g Q Q V E = + − + + − 12 1 2 34 3 4 ( )( ) ( )( ),    (9)
where g12 is the conductance of the Q1 and Q2 states and g34 is the 
conductance of the Q3 and Q4 states (g12 < g34), V is the holding po-
tential, and E is the reversal potential (see Table S1 for parameter 
values). Although it is possible to model the allosteric binding of 
Ca
2+ to P2X7R by adding new states to the scheme, each represent-
ing the fraction of receptors with a given number of occupied allo-
steric Ca
2+ binding sites (as well as occupied orthosteric agonist 
binding sites), the total number of these allosteric binding sites is 
not known, and the complexity of the scheme would become un-
necessarily large. For this reason, we model the effects of divalent 
cations using the aforementioned phenomenological approach.
Online supplemental material
Fig. S1 shows the effects of a P2X7R-specific antagonist on BzATP-
induced receptor activation and deactivation. Fig. S2 shows a Markov 
state model describing the binding and unbinding of BzATP to 
the P2X7R. Fig. S3 illustrates Hill functions describing alloste-
ric regulation of P2X7R by divalent cations, whereas Fig. S4 illus-
trates  the  effects  of  divalent  cations  on  receptor  deactivation. 
Table S1 shows parameter values and distributions used in model-
ing of P2X7R gating. Online supplemental material is available   
at http://www.jgp.org/cgi/content/full/jgp.201110647/DC1.
R E S U L T S
Extracellular calcium dependence of orthosteric  
agonist potency
To clarify whether bath Ca
2+ plays a role in the P2X7R 
permeability kinetics, we studied the concentration de-
pendence  of  ATP  and  BzATP  on  currents  using  the 
wild-type rat P2X7R expressed in HEK293 cells bathed 
in  2-mM  Ca
2+/1-mM  Mg
2+–containing  buffer  or  in   
Ca
2+-deficient/1-mM Mg
2+–containing buffer. All ex-
periments were performed with naive receptors (not 
previously exposed to agonist), and all recordings were 
performed in one cell per dish during a single agonist 
application/withdrawal. Fig. 1 illustrates the patterns of 
current responses in cells stimulated with ATP (A and B) 
and  BzATP  (C  and  D)  for  40  s  or  2  min  in  2-mM   
Ca
2+–containing (A and C) and Ca
2+-deficient (B and D)   
medium. In cells bathed in Ca
2+–containing medium, 
monophasic, slowly developing currents of small ampli-
tude were observed in response to 0.1 and 0.32 mM ATP 
(Fig. 1 A) and 3.2 and 10 µM BzATP (Fig. 1 C). As de-
scribed previously (Yan et al., 2008, 2010), at higher 
agonist concentrations (1–10 mM ATP and 32–320 µM 
BzATP), biphasic currents were observed, with a rapid 
initial rise in current (I1) followed by a slower second-
ary rise (I2) that we interpret as dilation of the pore. 
Clampfit 10.0 (Molecular Devices) predefined biexponential func-
tion ( ( ) exp( / ) exp( / )) f t A t A t = − + − 1 1 2 2 τ τ .  ATP
4 and BzATP
4 
concentrations were calculated using Theo Schoenmakers’ pro-
gram Chelator, which is freely available online. Numerical simula-
tions of the Markov state model were performed using MATLAB 
(Mathworks). Parameter fitting of f to the simulations of the Markov 
state model over the interval  a b , [ ] was performed by minimizing 
the error given by the L2 norm
  f f
b a
f t f t dt
a
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Kinetic model
A Markov state model consisting of eight states (Ci, closed states 
and Qi, open states, i = 1–4) describing the sequence of binding 
and unbinding of agonist to P2X7R was used (Fig. S2). Details of 
the scheme are available in Yan et al. (2010). In brief, each state 
corresponds to the fraction of receptors that are either unsensi-
tized or sensitized (Fig. S2, top and bottom row, respectively) with 
a given number of agonist binding sites occupied. Negative co-
operativity in agonist binding (i.e., a decrease in binding affinity 
with the occupation of each site) is assumed to occur only to un-
sensitized receptors (Fig. S2, top row). However, receptor sensiti-
zation (Fig. S2, bottom row) is assumed to restore symmetry of 
agonist binding and lead to dilation of the channel associated 
with each receptor. The allosteric binding of divalent extracellu-
lar Ca
2+ to the P2X7R has been added to the model as a new fea-
ture. This is done by assuming that the forward rates (k2, k4, and k6) 
decrease by a factor F and the backward rates (k1, k3, and k5) in-
crease by a factor (2  F) when bath extracellular calcium con-
centration ([Ca
2+]e) is increased. When F = 1, the model reduces 
to  the  previously  published  version,  and  this  happens  when 
[Ca
2+]e ≈ 2 mM. F is a decreasing Hill function (Fig. S3) and is 
given by
  F
e
=
+
α
β
β
2
2 2 [ ] DC
,  
where  is the maximum level of allosteric regulation (or inhibi-
tion) and  is the half-maximum level of divalent cations ([DC]e) 
required for such regulation.
The  mathematical  model  associated  with  this  Markov  state 
model (shown schematically in Fig. S2) is thus given by
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  dQ
dt
k AFC k F Q k F k AF Q
1
4 2 5 2 3 6 1 2 3 2 2 2 = + − − − + ( ) ( ( ) ) ,    (3)
  dQ
dt
k AFQ L Q k F L Q
2
6 1 2 3 5 3 2 3 2 = + − − + ( ( ) ) ,    (4)
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3
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but temporally coincides with extensive blebbing. Others 
have observed similar effects (Roger et al., 2008). Be-
cause the development of biphasic current reflects a 
transition from an open to a dilated state, these results 
indicate that the pore does not depend on bath Ca
2+.
The  calculated  values  of  ATP
4  concentrations  in 
Ca
2+-containing and -deficient media are shown in Fig. 1 
(A and B; numbers in parentheses above traces). Using the 
same program (the Maxc program for a two-chelator, two-
metal calculation), we also calculated the concentration 
The rate of dilation increased with elevation in agonist 
concentrations until, at the highest agonist concentra-
tions, the channels passed almost immediately to the   
dilated state, and the current consisted mostly of I1, as   
it did for the lowest agonist concentrations. The same 
pattern of response was also observed in cells bathed in 
Ca
2+-deficient medium, but with a leftward shift in ago-
nist concentration of 0.5 log units (Fig. 1, B and D; and 
Fig. 2 A). The “noise” current observed in response to   
1 and 3.2 mM ATP does not reflect low quality recording 
Figure 1.  Effects of bath calcium on P2X7R current. (A–D) Concentration dependence on ATP (A and B) and BzATP (C and D) of 
P2X7R current in single HEK293 cells bathed in 2-mM Ca
2+–containing (A and C) and Ca
2+-deficient (B and D) medium with 1 mM 
Mg
2+. In this and following figures, the whole-cell current recording was performed using Ca
2+-deficient pipette medium containing   
10 mM EGTA, and cells were held at 60 mV, if not otherwise specified. Horizontal bars above traces indicate the duration of agonist ap-
plication. The current response was monophasic at low agonist concentrations and biphasic at higher concentrations. The ratio between 
rapid (I1) and sustained (I2) currents also changed with the increase in agonist concentration, as described previously (Yan et al., 2010). 
All traces shown were obtained during the initial agonist application and are representative of at least five records per dose. Mean ± SEM 
values are shown in Fig. 2 A. Numbers without parentheses indicate total agonist concentrations used in experiments, and numbers in 
parentheses indicate free agonist concentration calculated using the Maxc program for two chelators and two metals. The responses to 
ATP (A vs. B) and BzATP (C vs. D) were similar when the free concentration of each agonist was similar. However, there was a Ca
2+-
dependent shift in the dose–response of 0.5 log units of total agonist concentration. Dotted lines separate I1 and I2 currents.  Yan et al. 441
One way to overcome this limitation is to have vari-
able Ca
2+ concentrations and identical free agonist 
concentrations.  As  estimated  by  the  Maxc  program   
calculations, these types of experiments are practically   
impossible to do with ATP because it acts as an ortho-
steric agonist for P2X7R in the submillimolar to milli-
molar  concentration  range.  Specifically,  binding  of 
divalent cations to ATP in this concentration range af-
fects not only the free agonist concentration but also 
the free divalent cation concentrations. Thus, to have 
minimum impact on divalent cation concentrations, an 
agonist should be at least in a micromolar concentra-
tion range, which is the case with BzATP. As shown in 
Fig. 3 D, calculations indicated that the free acid form 
of BzATP could be fixed at 1.6 µM by varying the total 
BzATP concentration from 17 to 90 µM and the total 
Ca
2+ concentration from 0 to 10 mM in the presence of 
constant (1 mM) Mg
2+.
However, this analysis is based on the assumption that 
BzATP binds calcium with a similar potency as ATP. 
Others have also estimated free BzATP concentration 
using an ATP binding program (Virginio et al., 1997). 
To test the validity of the calculation method for free 
BzATP concentration, we used a calcium ion selective 
electrode to estimate free bath Ca
2+ concentrations in 
the  presence  of  variable  concentrations  of  ATP  and 
BzATP. To exclude the impact of Mg
2+ on calcium mea-
surements, we used Mg
2+-free buffer with Ca
2+ fixed at 
950 µM and with ATP and BzATP concentrations of 0, 
1, 3.2, 10, 32, 100, and 320 µM. Fig. 2 B shows highly 
comparable  concentration-dependent  effects  of  ATP 
on  free  Ca
2+  concentration  obtained  by  calculations   
and by measurements, confirming the validity of this 
method. At 0–100-µM concentration, there was no sig-
nificant difference between values of free Ca
2+ in the 
presence of ATP and BzATP, whereas at higher agonist 
concentrations,  free  Ca
2+  concentrations  were  2–3% 
higher in the presence of BzATP than ATP. These re-
sults indicate that BzATP at the concentrations used in 
of the free acid form of BzATP in solution (Fig. 1, C and D).   
Comparing the values of the calculated free acid forms 
of the two agonists in Ca
2+-containing and Ca
2+-deficient 
medium  indicates  practically  identical  concentration 
responses in the absence and presence of Ca
2+. This is 
consistent with a hypothesis that ATP
4 rather than the 
divalent-bound ATP is the native agonist for this recep-
tor subtype. However, these results are also consistent 
with the hypothesis that bath Ca
2+ acts as an allosteric 
inhibitor and that 2 mM Ca
2+ causes a rightward shift in 
the potency of agonists of 0.5 log units independent 
of the concentration of the free acid form of agonists. 
In the next section, we consider experiments to distin-
guish between the two hypotheses.
Concentration dependence of agonist potency on 
extracellular calcium
In further experiments, we varied bath Ca
2+ concen-
trations (0.5, 1, 2, 5, and 10 mM), keeping identical   
(100 µM) total BzATP concentrations and 1 mM Mg
2+  
in buffer solution. Fig. 3 A shows that the calculated 
free  acid  concentrations  of  BzATP  progressively  de-
creased with an increase in bath Ca
2+ concentration. 
Representative traces of current responses during the 
initial agonist application are shown in Fig. 3 B. Appli-
cation of media containing 100 µM BzATP and 0.5 mM 
Ca
2+ resulted in high amplitude biphasic currents, whereas 
the current amplitude decreased with an increase in 
bath Ca
2+ concentrations to 5 and 10 mM. Fig. 3 C shows 
the correlation between divalent cation concentrations 
and amplitude of current response (left) and between 
free  BzATP  concentration  and  amplitude  of  current   
response (right) using mean ± SEM values. A similar 
correlation  coefficient  was  observed  in  both  cases,   
indicating that these experiments could not distin-
guish between the two hypotheses for the action of 
bath Ca
2+ as either an allosteric modulator (Fig. 3 C, 
left) or a factor determining free agonist concentration 
(Fig. 3 C, right).
Figure  2.  The  relationship  between 
bath  calcium  and  P2X7R  agonists.   
(A) Concentration-dependent effects of 
ATP and BzATP on the peak amplitude of 
current in cells bathed in Ca
2+-deficient 
(open circles) and 2-mM Ca
2+–contain-
ing  (closed  circles)  medium.  The  am-
plitude  of  current  was  measured  after 
40 s of agonist application. Data shown 
are mean ± SEM values from at least four 
responses per dose during initial agonist 
applications.  Representative  traces  are 
shown in Fig. 1. Arrows indicate leftward 
shifts in EC50 values, reflecting an increase in sensitivity to agonist stimulation in Ca
2+-deficient medium. (B) Concentration-dependent 
effects of ATP and BzATP on free Ca
2+ concentration. The background buffer contained 147 mM NaCl, 3 mM KCl, 10 mM glucose, 
and 10 mM HEPES supplemented with 0.95 mM Ca
2+. Free Ca
2+ concentration was measured with a calcium ion selective electrode as 
described in Materials and methods. Data shown are means from three experiments, and SEM values are within the symbols. The calcu-
lated free calcium concentrations were obtained using the Maxc program.442 Ca
2+ regulation of P2X7R
Others have shown that the rP2X7R-H130A mutant 
is resistant to Mg
2+ inhibition (Acuña-Castillo et al., 
2007). To examine whether this residue also accounts 
for allosteric action of Ca
2+, we stimulated cells with 
100 µM BzATP in Ca
2+-deficient and 10-mM Ca
2+–con-
taining medium. Like the wild-type receptor, the mu-
tant  receptor  also  responded  to  agonist  application 
with a delay in receptor activation and 15-fold decrease 
in  the  peak  amplitude  of  current  when  bathed  in   
10 mM Ca
2+ (Fig. 3, B and G). This indicates that dif-
ferent residues account for the allosteric action of Ca
2+ 
and Mg
2+.
Cells expressing wild-type receptors and clamped at 
60 mV also responded to agonist application with bipha-
sic currents, but the current was outward (Fig. 3 H).   
Furthermore, Ca
2+ inhibited receptor activation in a 
our experiments binds Ca
2+ with a comparable capacity 
to ATP.
Fig. 3 (E and F) summarizes the results of stimulation of 
cells with BzATP and bath Ca
2+ in concentrations shown 
in Fig. 3 D. Under such experimental conditions, the re-
lationship between total agonist concentration and the 
pattern of current response was lost. Practically, the low-
est total BzATP concentration (17 µM) was most effective, 
and the highest concentration (90 µM) was the least effec-
tive. Furthermore, although the free acid from of BzATP 
was identical in all four media, we still observed the full 
concentration-dependent inhibitory effect of Ca
2+ on the 
peak amplitude of current response. The finding that 
bath Ca
2+ affects P2X7R gating independently of the con-
centrations of the free acid form of agonists indicates the 
allosteric nature of action of this cation.
Figure 3.  Dependence on extracellular Ca
2+ concentration of BzATP-induced P2X7R current. (A) Calculated free BzATP concentra-
tion in medium containing 100 µM BzATP and variable concentrations of Ca
2+ in the presence of 1 mM Mg
2+. Horizontal dotted lines 
indicate solutions used for activation of P2X7R shown in B and C. (B) Typical patterns of P2X7R current in response to application of 
100 µM BzATP in medium containing 0.5, 5, and 10 mM Ca
2+. (C) Correlation between divalent cation concentrations ([DC]e) and peak 
amplitude of current responses (left) and between free BzATP concentration and peak amplitude of current response (right). r, correla-
tion coefficient. Data shown are means ± SEM (n = 4 per data point). (D–F) Variable current responses in cells stimulated with media 
containing identical free BzATP but variable Ca
2+ concentrations. (D) Comparable free BzATP concentrations achieved with variable 
total BzATP, 1 mM Mg
2+, and variable Ca
2+ concentrations. (E) A decrease in the amplitude of currents in response to media containing 
identical free BzATP concentrations (1.6 µM) but increasing Ca
2+ concentrations. Inset shows the current response to medium containing 
10 mM Ca
2+ on an enlarged scale. (F) Mean ± SEM values of peak current amplitude measured 40 s after application of BzATP. n = 4–6 
per data point. (G) Effects of bath Ca
2+ on the peak amplitude of current in cells expressing the P2X7R-H130A mutant; representative 
traces and mean ± SEM values from four experiments. (H and I) Concentration-dependent effects of bath Ca
2+ on the activation time 
and peak amplitude of current; representative traces (H) and mean ± SEM values from four experiments (I). hp, holding potential.  Yan et al. 443
(Fig.  4  A,  left)  or  4  min  in  Ca
2+-deficient  medium   
(Fig. 4 A, right). Superimposed records from these   
experiments show two phenomena. First, deactivation 
of receptors was dramatically slowed in cells bathed in 
Ca
2+-deficient medium, indicating that bath Ca
2+ re-
duces the potency of agonist. Second, repetitive stimu-
lation  slowed  receptor  deactivation  independently  of 
the status of bath Ca
2+ (Fig. 4 B). Both phenomena were 
also observed during repetitive application of 100 µM 
BzATP for 40 s (Fig. 4 C).
The effect of bath Ca
2+ on receptor deactivation was 
concentration dependent. Fig. 4 D (left) shows repre-
sentative traces (gray) with fitted biexponential curves 
(black) from cells bathed in media containing 0.5, 5, 
and 10 mM Ca
2+. From the fitting curves, the  τ2s were 
derived, and the mean ± SEM values were generated 
(Fig. 4 D, inset). To study the time course of Ca
2+ action, 
we replaced 2 mM Ca
2+–containing medium with Ca
2+-
deficient  medium  (Fig.  4  E,  horizontal  bars)  during 
washout of agonists. The addition of Ca
2+ rapidly (0.5 s) 
and reversibly affected the rate of receptor deactivation. 
The same effect was also observed in cells expressing 
P2X7R-H130A mutant (Fig. 4 F). Thus, bath Ca
2+ rap-
idly, and in a concentration-dependent manner, facili-
tates receptor deactivation.
concentration-dependent  manner  (Fig.  3,  H  and  I), 
which is highly comparable with that observed in cells 
clamped at 60 mV (Fig. 3, E and F). As Ca
2+ influx 
would be negligible in this condition, the results suggest 
that Ca
2+ probably does not act near the channel pore.
Calcium dependence of receptor deactivation
If bath Ca
2+ allosterically affects the potency of ortho-
steric ligands at P2X7R, it should also affect the rates of 
receptor deactivation. In general, the washout of ATP 
was accompanied by a relatively rapid decline of current 
(deactivation), whereas the decline of the current after 
washout of the more potent BzATP was slower (Fig. 1). 
In concentrations that caused biphasic responses when 
cells were bathed in Ca
2+-containing medium, the best 
approximation for decay of current after the washout of 
agonist was achieved using biexponential fitting, and 
the averaged decay constants τ1 and τ2  were about sev-
enfold larger for BzATP than for ATP (τ1 = 2.8 ± 0.5 vs. 
0.4 ± 0.2 s; τ2  = 14.9 ± 1.1 vs. 2.1 ± 0.2 s, respectively).
To study the effects of bath Ca
2+ on the kinetics of recep-
tor deactivation, we used several experimental approaches. 
In the first experiment, the same cells were repetitively 
stimulated with 100 µM BzATP for 1 s separated by wash-
out periods of 2 min in 2-mM Ca
2+–containing medium 
Figure 4.  Calcium dependence of P2X7R deactivation. (A) Repetitive 1-s application of BzATP in cells bathed in 2 mM Ca
2+ + 1 mM 
Mg
2+ (six applications, left) and Ca
2+-deficient medium + 1-mM Mg
2+ medium (four applications, right). (B) Superimposed records 
showing a slowing of receptor deactivation caused by repetitive agonist application (black) and by removal of Ca
2+ (gray). (C) Compari-
son of the rates of current deactivation during prolonged (40 s) agonist application in the presence and absence of bath Ca
2+. 1 and 2 are 
the first and second agonist applications. (D) Dependence of the rates of receptor deactivation on Ca
2+ concentrations. Representative 
traces (gray) and fitted biexponential curves (black). (inset) Bars indicate mean ± SEM values of τoff , 2  and asterisks indicate significant 
difference (P < 0.01) versus 0 mM Ca
2+. n = 5–10 per data point. (E and F) Example records of change in the rates of current deactivation 
by replacing 2-mM Ca
2+–containing medium with Ca
2+-deficient medium (indicated by horizontal bars) in cells expressing the wild-type (E) 
and H130A mutant (F) P2X7Rs.444 Ca
2+ regulation of P2X7R
of BzATP on current or by facilitated dissociation of re-
sidual bound agonist from binding sites, the latter be-
ing consistent with allosteric action of this cation. To 
clarify this issue, in further studies we used A438079 
(Torcis), a human P2X7R-specific competitive antago-
nist  (Nelson  et  al.,  2006;  McGaraughty  et  al.,  2007).   
In cells expressing rat P2X7R, A438079 applied alone 
did not generate any current (unpublished data). When 
applied together with 3.2 mM ATP, it reduced the peak 
amplitude  of  current  in  a  concentration-dependent 
manner (Fig. S1 A), with an estimated IC50 value of 
1 µM. A438079 also concentration dependently inhib-
ited 100-µM BzATP–induced current amplitude (Fig. S1 B) 
with a similar IC50 value. Furthermore, in cells with de-
veloped biphasic current caused by the application of 
100 µM BzATP, A438079 rapidly and in a dose-depen-
dent manner decreased the peak amplitude of current 
with an IC50 value of 0.3 µM (Fig. S1 C). When cells 
were stimulated with 32 µM BzATP, A438079 also inhib-
ited current with an IC50 of 0.3 µM. Together, these 
data show that A438079 also acts as a typical competitive 
orthosteric antagonist to rat receptor, with 3,000-fold 
higher potency than ATP and 200-fold higher potency 
than BzATP, and could be used to study effects of cal-
cium on the kinetics of receptor deactivation.
Fig. 5 A shows that A438079 facilitated deactivation 
of the wild-type receptor in both Ca
2+-containing (left) 
and Ca
2+-deficient medium (right) and that this effect 
was rapid (0.8 s). To further clarify this issue, we used 
the  T15E-P2X7R  mutant,  which  is  more  sensitive  to 
BzATP and, consequently, deactivates slowly (Yan et al., 
2010). When applied during the washout of free BzATP, 
A438079 also facilitated the mutant receptor deactiva-
tion. The effect of A438079 of increasing the rate of re-
ceptor deactivation was observed in cells bathed in both 
Ca
2+-containing and -deficient medium (Fig. 5 B). These 
results indicate that BzATP is partially rebound during 
the washout period and is replaced by a more potent li-
gand molecule. When deactivation of receptors was ini-
tiated by washing the cells with Ca
2+-deficient medium 
in the presence of A438079, the subsequent addition of 
2 mM Ca
2+ facilitated receptor deactivation (Fig. 5 C). 
These results indicate that the rapid effect of bath Ca
2+ 
on the current decay during the washout period is not 
dependent on the rebinding effect of orthosteric ago-
nists on P2X7R gating.
In our experimental conditions, HEK293 cells express 
mRNA transcripts for pannexin-1 (Panx1), but not Panx2 
and Panx3. The expression of Panx1 protein transcripts 
was below detection by Western blot analysis (Li et al., 
2011). The inhibitory effect of Ca
2+ on receptor activa-
tion was preserved in cells treated with 32 µM CBX, an 
inhibitor of Panx1 channels. Fig. 5 D shows the inhibi-
tory effect of 10 mM Ca
2+ on 100-µM BzATP–induced 
current in cells expressing the wild-type receptor and 
perfused with Ca
2+-deficient medium containing 32 µM 
Effects of A438079 and carbenoxolone (CBX) on receptor 
activation and deactivation
Facilitation of receptor deactivation by bath Ca
2+ could 
be explained either by inhibition of the rebound effect 
Figure 5.  Comparison of the effects of bath Ca
2+, A438079, and 
CBX on the rates of receptor deactivation. (A) Effects of A438079 
application on the rate of deactivation of the wild-type P2X7R 
after washout of 100 µM BzATP with 2-mM Ca
2+–containing (left) 
and Ca
2+-deficient (right) medium. The gray trace (left) shows 
receptor deactivation in the absence of A438079. For clarity, the 
activation phase is not shown. (B) Changes in the rate of T15E-
P2X7R deactivation by application of 100 µM A438079 in cells 
bathed in 2-mM Ca
2+–containing (left) and Ca
2+-deficient (right) 
medium. (C) Two examples of effects of 2 mM Ca
2+ on the rate of 
T15E-P2X7R deactivation in the presence of A438079. Arrows in-
dicate the time of Ca
2+ application; black traces, 2 mM Ca
2+; gray 
traces, Ca
2+-deficient medium. In all experiments, bath medium 
contained 1 mM Mg
2+, cells were stimulated with 100 µM BzATP, 
and the concentration of A438079 was 100 µM. (D) Effects of 10 mM 
Ca
2+ on the amplitude of 100-µM BzATP–induced current in cells 
expressing the wild-type receptor and bathed in Ca
2+-deficient 
medium with 32 µM CBX.  Yan et al. 445
conditions). To briefly summarize our results, we found 
that the model exhibited monophasic slow current re-
sponses at low BzATP concentrations (3.2 and 10 µM) 
and biphasic current responses that included fast and 
slow  components  at  high  BzATP  concentrations  (32, 
100, and 320 µM) during both the activation and deac-
tivation phases of the current. We suggested in Yan et al. 
(2010) that the slow component of the current exhib-
ited at high agonist concentrations is a result of the sen-
sitization of receptors (i.e., dilation of the channel pores 
associated with these receptors). This corresponds to a 
shift in the fraction of receptors in the top row to the 
bottom row of Fig. S2. The fast component of the activa-
tion phases gradually dominated over the slow compo-
nent as the agonist concentration was increased. With 
the additional feature included in the model, subject-
ing the model cells to Ca
2+-deficient medium ([Ca
2+]e = 
0 mM), as was done in Fig. 6 B, increased the potency of 
agonist binding (as a result of an increase in the value 
of the ratio F/[2  F]). A reduction in agonist concen-
tration by 0.5 log units generated the same outcomes 
obtained in Fig. 6 A, consistent with the cell recordings 
shown in Fig. 1 (C and D).
To investigate the effect of extracellular Ca
2+ (or diva-
lent cations in general) on current amplitudes, we stim-
ulated a single model cell with 100 µM BzATP and only 
varied [Ca
2+]e. Fig. 7 A shows that the simulated current 
CBX. These data indicate that even if Panx1 channels 
are expressed in HEK293 cells in sufficient numbers, 
their interaction with P2X7R does not account for inhi-
bition of receptor function by Ca
2+. Together with the 
findings that bath Ca
2+ affects receptor activation in a 
concentration-dependent  manner  and  independently 
of free agonist concentration, these experiments defini-
tively  show  that  Ca
2+  in  physiological  concentrations 
acts as a negative allosteric modulator.
Kinetic model for calcium-dependent allosteric regulation
To have a better understanding of the effects of bath 
Ca
2+ on P2X7R channel gating, we used a Markov state 
model consistent with the model presented in Yan et al. 
(2010), except for the inclusion of the allosteric regula-
tion exerted by [Ca
2+]e on the P2X7Rs, which was sug-
gested by the experimental results presented in Figs. 
1–4. This was done by assuming that [Ca
2+]e increases 
the backward rates (k1, k3, and k5) by the fraction 2  F 
and decreases the forward rates (k2, k4, and k6) by the 
fraction F. In Fig. 6, we show current simulations (ob-
tained  using  Eq.  9)  generated  by  stimulating  model 
cells (described by Eqs. 1–8) with increasing doses of 
agonist (BzATP) concentrations at two different levels 
of [Ca
2+]e: 2 and 0 mM. At 2-mM [Ca
2+]e, current simula-
tions were similar to those shown in Fig. 1 C (and identical 
to the ones displayed in Yan et al. [2010] under the same 
Figure 6.   Dependence of current simulations on BzATP and extracellular calcium concentrations. (A and B) Current simulations 
generated by the kinetic model, Eqs. 1–9, in the presence of 2 mM Ca
2+ (A) and in the absence (B) of bath Ca
2+ during 40-s and 2-min 
BzATP stimulation at increasing doses, as specified by the gray bars. Monophasic and biphasic responses are obtained at low and high 
concentrations of BzATP, respectively, in both cases, a result consistent with the experimental recordings (Fig. 1). The loss of allosteric 
inhibition exerted by extracellular Ca
2+ in B led to an increase in the potency of BzATP, which manifested itself in requiring less agonist 
concentration (a reduction of 70% compared with A) to produce the same response.446 Ca
2+ regulation of P2X7R
tions, the experimental curve might turn out to be sig-
moidal, as suggested here.
The P2X7R inhibition observed in Fig. 7 (A and B) is 
clearly not caused by a decrease in free agonist concen-
tration (as a result of Ca
2+ binding) because F and 2  F 
do not reflect this feature but rather the allosteric 
regulation. To confirm this, we repeated the same ex-
perimental procedure conducted in Fig. 3 (D–F) by 
initially stimulating a single model cell with the same 
level of free BzATP (obtained by varying both extracel-
lular Ca
2+ and BzATP concentrations in a manner simi-
lar to Fig. 3 D). Fig. 7 C shows that the simulated current 
amplitudes  decreased  with  the  increase  in  [Ca
2+]e, 
which is compatible with an allosteric regulation of the 
receptor  by  Ca
2+.  Extending  this  idea  to  a  heteroge-
neous population of model cells, as in Fig. 7 D, revealed 
that a negative correlation exists between current am-
plitudes and [Ca
2+]e, even though free BzATP in each 
case is the same, an outcome consistent with the exper-
imental results in Fig. 3 E.
The main advantage of using kinetic models of this 
nature is the ability to extract quantitative information 
about the fraction of receptors in each state. This may pro-
vide insight into how extracellular Ca
2+ allosterically inhib-
its receptor activation and facilitates receptor deactivation. 
For this reason, we have simulated in Fig. 8 the time evo-
lution of the two closed states, C1 (black) and C4 (gray) 
amplitudes decreased in proportions similar to those 
observed experimentally when [Ca
2+]e was gradually in-
creased from 1.5 to 3 and then to 11 mM (compare with 
Fig. 3 B). Extending this result to a heterogeneous pop-
ulation of model cells (randomly generated from the 
distributions listed in Table S1) stimulated by the same 
level of BzATP concentration (100 µM) and subjected 
to various levels of [Ca
2+]e (between 0.5 and 10 mM) 
with fixed (1 mM) Mg
2+ concentration revealed that the 
Ca
2+-dependent  dose–response  curve  for  the  current 
amplitude generated by the whole population, shown 
in Fig. 7 (B, left), is best fitted by a decreasing Hill func-
tion, with a Hill coefficient of n = 4 and half-maximum 
inhibition of IC50 = 4.1 mM. The best fit to the BzATP
4-
dependent dose–response curve, shown in Fig. 7 (B, 
right), was an increasing Hill function with n = 4 and 
EC50 = 3.9 µM (where BzATP
4 at each data point was 
calculated in a manner similar to that described in the 
Materials and methods section). It should be mentioned 
here  that  even  if  the  effect  of  extracellular  Ca
2+  was 
modeled differently, e.g., by assuming that F is a linearly 
decreasing function of [Ca
2+]e (considered experimen-
tally unrealistic), we would still get a Hill-like function 
for  both  Ca
2+-  and  free  BzATP–dependent  dose– 
response curves (unpublished data). It is possible that the 
fit in Fig. 3 C is linear because of the small number of 
data points; with data at a greater number of concentra-
Figure 7.  Dependency of current amplitudes on [Ca
2+]e and free BzATP agonist concentrations, as determined by the kinetic model, 
Eqs. 1–9. (A) Stimulating the kinetic model with 100 µM BzATP at three levels of [Ca
2+]e, 0.5, 2, and 10 mM in the presence of 1 mM 
Mg
2+, shows a decrease in current amplitude during [Ca
2+]e increase. (B) Best fit to the [Ca
2+]e-dependent (left) and free BzATP–de-
pendent (right) dose–response curves of current amplitudes, obtained from stimulating a heterogeneous population of 10 model cells 
(each generated by randomly selecting parameter values from the distributions listed in Table S1) with 100 µM BzATP. The [Ca
2+]e-
dependent dose–response curve is a decreasing Hill function, whereas the free BzATP–dependent dose–response curve is an increasing 
Hill function. (C) As in Fig. 3 E, current amplitudes obtained from stimulating the kinetic model with identical free BzATP concentra-
tions, achieved by variable BzATP and [Ca
2+]e, decrease with [Ca
2+]e increase. (D) As in Fig. 3 F, current amplitudes obtained from a 
heterogeneous population of 10 model cells exhibit a decrease with [Ca
2+]e during stimulation with identical concentrations of free 
BzATP in each simulation. Error bars indicate mean ± SEM values of current amplitude.  Yan et al. 447
both the presence and absence of external Ca
2+ as a re-
sult of receptor sensitization, as was previously described 
in Yan et al. (2010). As illustrated in Fig. 8, the allosteric 
inhibition exerted by Ca
2+ led to a reduction in receptor 
accumulation in state Q2, causing a decrease in the frac-
tion of sensitized receptors (i.e., a decline in the number 
of P2X7Rs transitioning from the top row to the bottom 
row of Fig. S2). Consequently, during washout, the deac-
tivation phase at higher [Ca
2+]e is primarily governed by 
the backward rates (k1, k3, and k5) of the unsensitized 
states (Fig. S2, top row), which are faster than those (k1) 
of the sensitized states (Fig. S2, bottom row), in contrast 
to the behavior in Ca
2+-deficient medium (see Fig. S4 for 
the breakdown into sensitized and unsensitized recep-
tors). Increasing the duration of stimulation to 40 s in 
Fig. 9 C resulted in similar outcomes; namely, slower de-
activation phases in the absence of extracellular Ca
2+ for 
both  first  (left)  and  second  pulses  (right).  In  other 
words, such behavior was independent of how long the 
model cells were stimulated for.
To further examine the effects of various concentrations 
of extracellular Ca
2+ on the deactivation phase of the 
current, we subjected a naive model cell, stimulated with 
100 µM BzATP for 40 s, to 0.5-, 5-, and 10-mM [Ca
2+]e. The 
deactivation phases of simulated currents, normalized by 
their maximum values and shown in Fig. 9 (D, left), exhib-
ited similar outcomes to those observed experimentally in 
Fig. 4 D: the increase in [Ca
2+]e led to a progressive in-
crease in the rate of receptor deactivation. Extending this 
study to a heterogeneous population of 10 model cells 
subjected to 0-, 0.5-, 2-, and 5-mM [Ca
2+]e and stimu-
lated with 100 µM BzATP revealed that the average time 
in A, and the two open states, Q1 + Q2 (black) and Q3 + Q4 
(gray) in B, to illustrate how maintaining the same level 
of free BzATP (by varying [Ca
2+]e and BzATP concentra-
tion identified by the [DC]e values and gray bars in Fig. 8, 
respectively) could produce the effects observed in Figs. 3 
and 7. Fig. 8 A shows that even though the increase in 
[Ca
2+]e  only  decreased  the  activation  of  naive  states 
slightly, the accumulation of receptors in Q1 + Q2 was 
significantly reduced (Fig. 8 B), leading to a significant 
reduction in the sensitization of receptors quantified by 
the fraction Q3 + Q4 (during stimulation) and C4 (dur-
ing washout). This explains the progressive loss of the 
slow component (I2) of the activation phase of the cur-
rent observed in Figs. 3 E and 7 C. The loss of the sensi-
tized receptor component is also responsible for the loss 
of the slow deactivation component at high agonist con-
centration (Fig. S4). This explains the increase in the 
deactivation rate observed in Fig. 7 C.
The dependency of the deactivation phase of current 
on extracellular Ca
2+ observed in Fig. 3 was also repro-
duced by the model, as shown in Fig. 9. Activation of a 
naive model cell repeatedly with 100 µM BzATP for 1 s 
(Fig. 9 A) in the presence of 2 mM Ca
2+ (Fig. 9 A, left) 
and the absence of extracellular Ca
2+ (Fig. 9 A, right) 
showed that it takes longer for the current to go back to 
baseline in the latter case (55 s) than in the former (11 s). 
This is confirmed in Fig. 9 B, where the simulated cur-
rents obtained in each BzATP pulse, normalized by 
their maximum values, exhibited a faster deactivation 
phase in Ca
2+-containing medium (black) than in Ca
2+ -
deficient medium (gray). Furthermore, subsequent pulses 
showed slower deactivation than the former pulses in 
Figure 8.  Simulated response to a 1-min stimulation with various concentrations of BzATP. Gray bars indicate the various concentra-
tions of BzATP. (A) Fraction of receptors in the two closed states, C1 (black) and C4 (gray). (B) Fraction of receptors in open states, Q1 + Q2 
(black), and dilated states, Q3 + Q4 (gray). Free BzATP in each stimulation was identical. As in Fig. 7 C, this was achieved by variable 
BzATP and [Ca
2+]e (identified by the [DC]e values, top row). Increased [Ca
2+]e increases the allosteric inhibition of P2X7R and thus 
reduces receptor sensitization and pore dilation (i.e., leads to a shift to the bottom row of Fig. S2).448 Ca
2+ regulation of P2X7R
Consistent  with  findings  by  others  (Surprenant  et  al., 
1996; Virginio et al., 1997; Klapperstück et al., 2001), 
bath Ca
2+ inhibited agonist-induced current in a concen-
tration-dependent manner, causing a rightward shift in 
dose–response experiments. In our experimental condi-
tions with naive receptors, the difference was 0.5 log 
units  when  cells  were  bathed  in  Ca
2+-deficient  and   
2-mM Ca
2+–containing medium. For P2X4R, it has also 
been shown that bath Ca
2+ affects the permeability state 
of the receptor; in the presence of bath Ca
2+, the channel 
is only permeable to small cations, whereas in cells bathed 
in Ca
2+-deficient medium, the channel pore is permeable 
to larger organic cations (Khakh et al., 1999). This find-
ing  was  confirmed  more  recently  using  fast-scanning 
atomic force microscopy (Shinozaki et al., 2009).
Initially, it was suggested that P2X7R is activated 
rapidly (within milliseconds) after application of ago-
nists, followed by a gradual (within seconds to minutes) 
increase in permeability to organic cations and fluo-
rescent dyes (Surprenant, 1996; Chessell et al., 1997; 
constant τoff , 2  obtained from fitting a biexponential func-
tion to the deactivation phases, decreased as [Ca
2+]e was 
increased, a result consistent with the experimentally 
observed outcomes in Fig. 4 D. As indicated earlier, the de-
crease is caused by a gradual loss of the sensitized compart-
ment responsible for the slow deactivation (as illustrated 
in Fig. 8 and Fig. S4). Finally, alternating [Ca
2+]e between 
2 and 0 mM during the deactivation phase of the simu-
lated current only (as shown in Fig. 9 E) repetitively for 3 s 
(left) or once for 5 s at the onset of the deactivation phase 
(right) exhibited similar outcomes to those observed in 
Fig. 4 E; namely, fast deactivation at high [Ca
2+]e, slow de-
activation at low [Ca
2+]e, and instantaneous change between   
these two distinct behaviors once the [Ca
2+]e is altered.
D I S C U S S I O N
We have shown here that the agonistic actions of ATP and 
BzATP on P2X7R were affected by bath Ca
2+ concentra-
tion in the presence of fixed Mg
2+ concentration (1 mM). 
Figure  9.  Dependence  of  P2X7R  deactiva-
tion on [Ca
2+]e as determined by the kinetic 
model, Eqs. 1–9. (A) Repetitive 1-s stimula-
tion with 100 µM BzATP in the presence of   
2 mM (left) and in the absence (right) of extra-
cellular Ca
2+ (compare with Fig. 4 A). (B) Cur-
rents from A normalized by their maximum   
amplitudes show that the deactivation compo-
nents of these currents are slower in Ca
2+-defi-
cient medium (gray) than in Ca
2+-containing   
medium (black). Slowing of deactivation with   
each  subsequent  pulse  occurs  with  or  with-
out extracellular Ca
2+ (compare with Fig. 4 B).   
(C)  Stimulating  the  kinetic  model  with   
100 µM BzATP for 40 s in the presence (black) 
and absence (gray) of extracellular Ca
2+ and 
normalizing  current  amplitudes  by  their 
maximum values result in both faster sensi-
tization (and pore dilation) and also slower 
deactivation  in  the  absence  of  extracellular 
Ca
2+ during both the first (left) and second 
(right) stimulations (compare with Fig. 4 C). 
(D) Deactivation components normalized by 
their maximum values during 100-µM BzATP 
stimulation for 40 s. Decreasing [Ca
2+]e from 
10 to 5 and then 0.5 mM slows deactivation 
(left). The slow time constant  τoff2  (right), 
obtained from fitting biexponential curves to 
the deactivation curves obtained from stimu-
lating 10 heterogeneous populations of simu-
lated cells, decreases with [Ca
2+]e (compare 
with  Fig.  4  D).  Error  bars  indicate  mean  ±   
SEM  values  of  τoff2.   (E)  Calcium  removal 
during P2X7R deactivation at two disjointed 
2-s intervals (left) and one 5-s interval (right) 
results in slower deactivation (compare with 
Fig. 4, E and F). Simulated currents were gen-
erated for a 40-s application of 100 µM BzATP 
in the presence of 2-mM [Ca
2+]e and normal-
ized by their maximum values.  Yan et al. 449
argue against the hypothesis that Ca
2+ effects on P2X7R 
activation is through Panx1 interacting with P2X7R. First, 
the expression of Panx1 protein in HEK293 cells in our 
experiments is very low, below the detection by Western 
blot analysis (Li et al., 2011), and P2X7R protein is over-
expressed, suggesting that only a small fraction of recep-
tors could be associated with Panx1, in contrast to almost 
complete inhibition of current by 10 mM Ca
2+. Second, in 
cells bathed in medium containing 32 µM CBX, an inhibi-
tor of Panx1 channels, the inhibitory effect of high Ca
2+ 
on P2X7R activation was not changed.
In our study, the application of agonists and antago-
nist and their removal was performed using an ultra-
rapid perfusion system with good time resolution (Yan 
et al., 2006). In general, the time required for washout 
of agonist inversely correlates with the potency of ago-
nist for binding sites (Rettinger and Schmalzing, 2004). 
Consistent with this conclusion, we observed that the 
reduced potency of ATP compared with BzATP to acti-
vate P2X7R was accompanied by a rapid decay of cur-
rent after washout of ATP and a slow decay of current 
after washout of BzATP. We also observed that removal 
of Ca
2+ in the presence of 1 mM Mg
2+ slowed the rates   
of receptor deactivation in a concentration- and time- 
dependent manner, further supporting the conclusion 
that bath Ca
2+ affects the potency of agonist. However, 
during  repetitive  agonist  application,  we  observed  a 
progressive decrease in the rates of receptor deactiva-
tion, which we previously termed receptor sensitization 
(Yan et al., 2010). Here, we showed that this process   
occurs in both Ca
2+-containing and -deficient medium,   
indicating  that,  like  pore  dilation,  sensitization  of   
receptors is not influenced by bath Ca
2+.
To study the influence of allosteric ligands on the oc-
cupancy of P2X7R orthosteric sites, others have ana-
lyzed receptor deactivation in the presence and absence 
of  orthosteric  and  allosteric  agonists  and  antagonists 
(Bianchi and Macdonald, 2001). Previous studies indi-
cated that A438079 is a human P2X7R-specific competi-
tive antagonist (Nelson et al., 2006; McGaraughty et al., 
2007). Our experiments showed that this compound 
also  acts  as  a  competitive  orthosteric  antagonist  for 
rP2X7R. The potency of this antagonist was 200-fold 
higher than BzATP, a critical feature in experiments on 
the kinetics of receptor deactivation.
When A438079 was applied during the washout pe-
riod, it facilitated deactivation in Ca
2+-containing and 
Ca
2+-deficient medium with similar rates. The same re-
sults were obtained with the T15E-P2X7R mutant, which 
is more sensitive to BzATP and, consequently, deacti-
vates more slowly (Yan et al., 2010). We interpreted this 
observation as an indication that a fraction of BzATP re-
leased from the binding domain during the washout pe-
riod rebinds, and that process is reduced or abolished in 
the presence of a more potent competitive antagonist. 
We also observed that deactivation of receptors in the 
Michel et al., 1999), which parallels the presence of I1 
and I2 in our experiments. However, several observa-
tions suggest that fluorescent dye entry occurs through 
a separate pathway than organic cations (Petrou et al., 
1997; Klapperstück et al., 2000), and the coupling of 
P2X7R to Panx1 channels was suggested to account for 
cellular entry of fluorescent dyes (Pelegrin and Surpre-
nant, 2006). Our recent data on this topic are consistent 
with the original hypothesis of P2X7R pore dilating dur-
ing  the  sustained  agonist  application,  including  the 
finding that I2 current growth temporally coincides with 
the transition from an open to a dilated state (Yan et al., 
2008, 2010). Here, we show that removal of bath Ca
2+ 
was not essential for the development of a secondary 
current growth (Fig. 1). Dilation of the P2X2R pore also 
does not require removal of bath Ca
2+ (Chaumont and 
Khakh, 2008). Our data do not exclude the possibility 
that Panx1 contributes to dye uptake in P2X7R-expressing 
HEK293 cells and do not argue against the role of Panxs 
in other purinergic signaling functions. Several recent 
publications (Dubyak, 2009), including our own work 
(Li et al., 2011), indicate that Panxs release ATP and 
that this action may include interactions with P2XRs.
A rightward shift in the potency of two orthosteric 
agonists in cells bathed in medium containing 2 mM 
Ca
2+ was not visible when the calculated free agonist 
concentration was used in concentration response rela-
tionship analysis. Others have reached similar conclu-
sions in experiments using Ca
2+-deficient medium and 
manipulating bath Mg
2+ concentrations (Klapperstück 
et al., 2001; Liu, M., S.D. Silberberg, and K.J. Swartz. 
2011. ATP
4 activates P2X receptors. Annual Biophysi-
cal Meeting. 1472-Pos.). This is consistent with the hy-
pothesis  that  ATP
4,  rather  than  the  divalent-bound 
ATP,  is  the  native  agonist  for  this  receptor  subtype 
(Dahlquist and Diamant, 1974; Cockcroft and Gomperts, 
1979; Di Virgilio et al., 1998).
However, these experiments do not exclude the possi-
bility that 2 mM Ca
2+ causes a rightward shift in the po-
tency of agonists of 0.5 log units independently of the 
concentration of the free acid form of agonists. To over-
come limitations in the interpretation of such data, we 
performed experiments with variable agonist and bath 
Ca
2+  concentrations  leading  to  a  constant  free  agonist 
concentration. Under such experimental conditions, we 
still observed a concentration-dependent inhibitory effect 
of bath Ca
2+ on receptor functions, clearly indicating that 
this cation exerts inhibitory effects on gating indepen-
dently of the concentration of orthosteric agonists. Re-
cently, it was shown that the rP2X7R-H130A mutant is 
resistant to Mg
2+ inhibition (Acuña-Castillo et al., 2007), 
reinforcing the hypothesis that this metal also acts through 
an allosteric mechanism. Here, we showed that this resi-
due does not account for the effects of Ca
2+ on agonist-in-
duced activation of receptors. We also showed that Ca
2+ 
does  not  act  near  the  channel  pore.  Finally,  our  data   450 Ca
2+ regulation of P2X7R
respectively) Hill-like functions with n = 4 and IC50 =   
4.1 mM for the former and EC50 = 3.9 µM for the latter. 
The  structures  of  these  response  curves  were  found   
to be independent of the assumed Ca
2+ dependency of   
the inhibition, suggesting that the experimental dose– 
response curves obtained here might be affected by the 
small number of concentrations used.
The effect of extracellular Ca
2+ on P2X7R could have 
been modeled by including additional states character-
izing the allosteric binding of Ca
2+ to the receptor. The 
lack of information about the number of these binding 
sites and the potential increase in complexity of the   
kinetic model associated with such an approach prompted 
us to model this effect using Ca
2+-dependent Hill func-
tions that directly acted on the binding and unbinding 
of the orthosteric agonist. Even though the use of this 
latter approach cannot determine how many allosteric 
binding sites the receptor may possess, it shows that the 
diverse effects of extracellular Ca
2+ can all be accounted 
for by a common effect on binding and unbinding rates 
of agonist.
In summary, our investigations show that the binding 
of the orthosteric agonists ATP and BzATP to P2X7R 
causes gating transitions from closed to open to dilated 
states (Fig. 10 A), resulting in the generation of mono-
phasic  currents  in  intermediated  concentration  range 
and biphasic currents at higher agonist concentration 
presence of A438079 is facilitated by the addition of Ca
2+ 
to bath medium, clearly indicating that the effect of Ca
2+ 
on the rate of receptor deactivation is also present un-
der conditions in which the rebinding effect of BzATP 
on the rate of deactivation was practically eliminated.
Some of these features of P2X7Rs were better under-
stood by using a minimal kinetic Markov state model 
that incorporated not only the orthosteric regulation ex-
erted by the agonist (which could lead to receptor sensi-
tization)  but  also  the  allosteric  regulation  exerted  by 
extracellular Ca
2+. The model, which was previously de-
veloped in Yan et al. (2010), integrated the allostery of 
Ca
2+ in a simplified manner by assuming that an increase 
in [Ca
2+]e accelerated agonist unbinding and impeded 
agonist binding by factors that depended sigmoidally on 
[Ca
2+]e.  This  model  not  only  preserved  the  essential 
properties of current recording associated with agonist 
stimulation but also captured the diverse effects of 
[Ca
2+]e on the channel. It showed that the loss of the 
second phase of the current at high [Ca
2+]e is caused by 
a decline in the number of sensitized receptors, which in 
turn led to an increase in the rate of deactivation, because 
backward rates of unsensitized receptors are faster than 
those of sensitized receptors. The model also revealed 
that Ca
2+-dependent and free BzATP–dependent dose–
response curves obtained from a heterogeneous pop-
ulation of model cells are (decreasing and increasing, 
Figure 10.  Orthosteric (BzATP) facilitation and allosteric (Ca
2+) inhibition of P2X7R. (A) In resting conditions (no agonist bound), 
the naive P2X7R is a symmetrical trimer, with three binding sites having equal and high affinity for orthosteric agonists, and is closed. 
The occupation of one binding site by agonist does not open the pore but leads to the loss of symmetry and an assumed reduction in 
the affinity of the two remaining binding sites as a result of a conformational change. When a second site is occupied, the affinity of the 
remaining binding site is further reduced, but the channel opens in a low conductance state. When three binding sites are occupied, 
however, symmetry is restored, and the binding rates revert to those of a naked receptor, allowing the pore to gradually dilate to a 
high conductance state and to sensitize. (B) The naive receptor in the open state generates monophasic currents with peak amplitude 
determined by BzATP concentration. The naive receptor at high BzATP concentration dilates and generates high amplitude biphasic 
currents. (C) Dependence of the peak current amplitude, measured 40 s after agonist application, on orthosteric and allosteric agonist 
concentrations. Gray trace, concentration dependence on BzATP of the peak current response of naive receptors in the presence of 
physiological bath Ca
2+ concentration. Red trace, concentration dependence on BzATP of the peak current response of sensitized re-
ceptors, termed orthosteric facilitation, in the presence of physiological Ca
2+ concentration. Green trace, concentration dependence on 
BzATP of the peak current response of naive receptors in the presence of elevated bath Ca
2+. For details on orthosteric facilitation, see 
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